Portfolio company
Graph Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GraphTX
The company develops a platform for precision drug discovery by mapping live patient immune cell behaviour to identify therapeutic targets for inflammatory diseases.
Aizen Therapeutics
This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.
Epana Bio
This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.
Immunara
This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.
Modulus Therapeutics
This company develops engineered NK-cell therapies for autoimmune disease patients using a generative design and rapid prototyping platform.
Scipher Medicine
This company develops blood tests that use artificial intelligence to match autoimmune disease patients with effective therapies for clinicians and pharmaceutical partners.
Epana
The company develops precision immune cell therapies and diagnostic atlases using genomics and artificial intelligence for patients with autoimmune diseases.
Seismic Therapeutic
The company develops immunology therapies for autoimmune and allergic diseases using machine learning for biologics discovery in the deep-tech sector.